Search

Your search keyword '"Endo, Tomoyuki"' showing total 30 results
Start Over Author "Endo, Tomoyuki" Publisher wiley
30 results on '"Endo, Tomoyuki"'

1. Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia

Author

Sekiguchi, Naohiro, primary, Rai, Shinya, additional, Munakata, Wataru, additional, Suzuki, Kenshi, additional, Handa, Hiroshi, additional, Shibayama, Hirohiko, additional, Endo, Tomoyuki, additional, Terui, Yasuhito, additional, Iwaki, Noriko, additional, Fukuhara, Noriko, additional, Tatetsu, Hiro, additional, Iida, Shinsuke, additional, Ishikawa, Takayuki, additional, Iguchi, Daisuke, additional, and Izutsu, Koji, additional

Published
2022
Full Text
View/download PDF

2. National Survey of Hepatobiliary and Pancreatic Surgery in Hemophilia Patients in Japan

Author

Yoshimoto‐Haramura, Tomoko, primary, Hidaka, Masaaki, additional, Hasegawa, Kiyoshi, additional, Suzumura, Kazuhiro, additional, Takemura, Nobuyuki, additional, Hama, Naoki, additional, Mizuno, Takashi, additional, Nomi, Takeo, additional, Kobayashi, Tsuyoshi, additional, Sano, Keiji, additional, Yokomizo, Hiroshi, additional, Nitta, Hiroyuki, additional, Kurata, Masanao, additional, Hasegawa, Yasushi, additional, Nagayama, Minoru, additional, Tani, Masaji, additional, Fukumoto, Takumi, additional, Ohta, Masayuki, additional, Hayashi, Hironori, additional, Taniguchi, Hiroki, additional, Ishino, Shinichiro, additional, Aihara, Tsukasa, additional, Murase, Takaaki, additional, Tsuchida, Akihiko, additional, Shimamura, Tsuyoshi, additional, Marubashi, Shigeru, additional, Kaneko, Junichi, additional, Hara, Takanobu, additional, Matsushima, Hajime, additional, Soyama, Akihiko, additional, Endo, Tomoyuki, additional, and Eguchi, Susumu, additional

Published
2021
Full Text
View/download PDF

3. Indications and waiting list priority for deceased donor liver transplantation in HIV/HCV co‐infected hemophilic patients in Japan through contaminated blood product

Author

Eguchi, Susumu, primary, Egawa, Hiroto, additional, Eguchi, Hidetoshi, additional, Uehira, Tomoko, additional, Endo, Tomoyuki, additional, Genda, Takuya, additional, Shinoda, Masahiro, additional, Hasegawa, Kiyoshi, additional, Shimamura, Tsuyoshi, additional, Tsukada, Kunihisa, additional, Hara, Tetsuya, additional, Nakao, Kazuhiko, additional, Yatsuhashi, Hiroshi, additional, Yotsuyanagi, Hiroshi, additional, Natsuda, Koji, additional, Soyama, Akihiko, additional, Hidaka, Masaaki, additional, Hara, Takanobu, additional, and Takatsuki, Mitsuhisa, additional

Published
2021
Full Text
View/download PDF

4. A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia

Author

Sekiguchi, Naohiro, primary, Rai, Shinya, additional, Munakata, Wataru, additional, Suzuki, Kenshi, additional, Handa, Hiroshi, additional, Shibayama, Hirohiko, additional, Endo, Tomoyuki, additional, Terui, Yasuhito, additional, Iwaki, Noriko, additional, Fukuhara, Noriko, additional, Tatetsu, Hiro, additional, Iida, Shinsuke, additional, Ishikawa, Takayuki, additional, Shiibashi, Ryota, additional, and Izutsu, Koji, additional

Published
2020
Full Text
View/download PDF

5. RIC-HSCT for MF/SS

Author

Shiratori, Souichi, Fujimoto, Katsuya, Nishimura, Machiko, Hatanaka, Kanako C., Kosugi-Kanaya, Mizuha, Okada, Kohei, Sugita, Junichi, Shigematsu, Akio, Hashimoto, Daigo, Endo, Tomoyuki, Kondo, Takeshi, Abe, Riichiro, Hashino, Satoshi, Matsuno, Yoshihiro, Shimizu, Hiroshi, and Teshima, Takanori

Subjects
graft-versus-lymphoma effect, mycosis fungoides, allogeneic hematopoietic stem cell transplantation, Sezary syndrome, reduced-intensity conditioning
Abstract

Advanced-stage mycosis fungoides and Sezary syndrome (MF/SS) have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (HSCT), particularly using a reduced-intensity conditioning (RIC) regimen, is a promising treatment for advanced-stage MF/SS. We performed RIC-HSCT in nine patients with advanced MF/SS. With a median follow-up period of 954days after HSCT, the estimated 3-year overall survival was 85.7% (95% confidence interval, 33.4-97.9%) with no non-relapse mortality. Five patients relapsed after RIC-HSCT; however, in four patients whose relapse was detected only from the skin, persistent complete response was achieved in one patient, and the disease was manageable in other three patients by the tapering of immunosuppressants and donor lymphocyte infusion, suggesting that graft-versus-lymphoma effect and "down-staging" effect from advanced stage to early stage by HSCT improve the prognosis of advanced-stage MF/SS. These results suggest that RIC-HSCT is an effective treatment for advanced MF/SS.

Published
2016

6. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation

Author

Hidaka, Daisuke, primary, Hayase, Eiko, additional, Shiratori, Souichi, additional, Hasegawa, Yuta, additional, Ishio, Takashi, additional, Tateno, Takahiro, additional, Okada, Kohei, additional, Goto, Hideki, additional, Sugita, Junichi, additional, Onozawa, Masahiro, additional, Nakagawa, Masao, additional, Kahata, Kaoru, additional, Endo, Tomoyuki, additional, Hashimoto, Daigo, additional, and Teshima, Takanori, additional

Published
2018
Full Text
View/download PDF

7. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation

Author

Miyashita, Naohiro, Endo, Tomoyuki, 1000070455632, Onozawa, Masahiro, Hashimoto, Daigo, 1000070333606, Kondo, Takeshi, Fujimoto, Katsuya, Kahata, Kaoru, Sugita, Junichi, Goto, Hideki, Matsukawa, Toshihiro, 1000060271665, Hashino, Satoshi, 1000040284096, Teshima, Takanori, Miyashita, Naohiro, Endo, Tomoyuki, 1000070455632, Onozawa, Masahiro, Hashimoto, Daigo, 1000070333606, Kondo, Takeshi, Fujimoto, Katsuya, Kahata, Kaoru, Sugita, Junichi, Goto, Hideki, Matsukawa, Toshihiro, 1000060271665, Hashino, Satoshi, 1000040284096, and Teshima, Takanori

Abstract

Background: Human herpesvirus 6 (HHV-6) encephalitis/myelitis is now a well-known complication after allogeneic stem cell transplantation (allo-HSCT), particularly after cord blood transplantation (CBT). In this study, we evaluated the risk factors of HHV-6 encephalitis/myelitis. Methods: We evaluated 253 patients who received allo-HSCT from 2007 to 2015 at our institute. HHV-6 encephalitis/myelitis was defined as HHV-6 DNA detection in the cerebrospinal fluid or peripheral blood by polymerase chain reaction in the presence of typical manifestations without other concurrent condition that led to the manifestations. Results: HHV-6 encephalitis/myelitis occurred in 11 patients (4.5%) (9 encephalitis, 3.7%; 2 myelitis, 0.8%). Multivariate analysis showed that CBT, mycophenolate mofetil (MMF) for graft-versus-host disease prophylaxis, history of allogeneic hematopoietic stem cell transplantation (allo-HSCT), and engraftment syndrome (ES) were significantly associated with incidence of HHV-6 encephalitis/myelitis (P=.025, P=.017, P=.017, and P=.014, respectively). Conclusion: Although it has been shown that CBT, ES, and history of allo-HSCT are risk factors for HHV-6 encephalitis/myelitis, our study demonstrated MMF is also a risk factor for the disease.

Published
2017

8. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

Author

Murata Makoto, Maeda Yoshinobu, Masuko Masayoshi, Onishi Yasushi, Endo Tomoyuki, Terakura Seitaro, Ishikawa Yuichi, Iriyama Chisako, Ushijima Yoko, Goto Tatsunori, Fujii Nobuharu, Tanimoto Mitsune, Kobayashi Hironori, Shibasaki Yasuhiko, Fukuhara Noriko, Inamoto Yoshihiro, SUZUKI, Ritsuro, Kodera Yoshihisa, Matsushita Tadashi, Kiyoi Hitoshi, Naoe Tomoki, Nishida Tetsuya, Murata Makoto, Maeda Yoshinobu, Masuko Masayoshi, Onishi Yasushi, Endo Tomoyuki, Terakura Seitaro, Ishikawa Yuichi, Iriyama Chisako, Ushijima Yoko, Goto Tatsunori, Fujii Nobuharu, Tanimoto Mitsune, Kobayashi Hironori, Shibasaki Yasuhiko, Fukuhara Noriko, Inamoto Yoshihiro, SUZUKI, Ritsuro, Kodera Yoshihisa, Matsushita Tadashi, Kiyoi Hitoshi, Naoe Tomoki, and Nishida Tetsuya

Published
2017

9. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

Author

Murata, Makoto, primary, Maeda, Yoshinobu, additional, Masuko, Masayoshi, additional, Onishi, Yasushi, additional, Endo, Tomoyuki, additional, Terakura, Seitaro, additional, Ishikawa, Yuichi, additional, Iriyama, Chisako, additional, Ushijima, Yoko, additional, Goto, Tatsunori, additional, Fujii, Nobuharu, additional, Tanimoto, Mitsune, additional, Kobayashi, Hironori, additional, Shibasaki, Yasuhiko, additional, Fukuhara, Noriko, additional, Inamoto, Yoshihiro, additional, Suzuki, Ritsuro, additional, Kodera, Yoshihisa, additional, Matsushita, Tadashi, additional, Kiyoi, Hitoshi, additional, Naoe, Tomoki, additional, and Nishida, Tetsuya, additional

Published
2017
Full Text
View/download PDF

10. Disseminated toxoplasmosis after hematopoietic stem cell transplantation showing unusual magnetic resonance images

Author

Tateno, Takahiro, primary, Onozawa, Masahiro, additional, Hashiguchi, Junichi, additional, Ishio, Takashi, additional, Yuzawa, Sayaka, additional, Matsuoka, Satomi, additional, Kosugi-Kanaya, Mizuha, additional, Okada, Kohei, additional, Shiratori, Souichi, additional, Goto, Hideki, additional, Kimura, Taichi, additional, Sugita, Junichi, additional, Nakagawa, Masao, additional, Hashimoto, Daigo, additional, Kahata, Kaoru, additional, Fujimoto, Katsuya, additional, Endo, Tomoyuki, additional, Kondo, Takeshi, additional, Tanaka, Shinya, additional, Hashino, Satoshi, additional, and Teshima, Takanori, additional

Published
2017
Full Text
View/download PDF

11. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation

Author

Miyashita, Naohiro, primary, Endo, Tomoyuki, additional, Onozawa, Masahiro, additional, Hashimoto, Daigo, additional, Kondo, Takeshi, additional, Fujimoto, Katsuya, additional, Kahata, Kaoru, additional, Sugita, Junichi, additional, Goto, Hideki, additional, Matsukawa, Toshihiro, additional, Hashino, Satoshi, additional, and Teshima, Takanori, additional

Published
2017
Full Text
View/download PDF

12. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome

Author

Shiratori, Souichi, Fujimoto, Katsuya, Nishimura, Machiko, Hatanaka, Kanako C., Kosugi-Kanaya, Mizuha, Okada, Kohei, Sugita, Junichi, Shigematsu, Akio, Hashimoto, Daigo, Endo, Tomoyuki, Kondo, Takeshi, Abe, Riichiro, Hashino, Satoshi, Matsuno, Yoshihiro, Shimizu, Hiroshi, Teshima, Takanori, Shiratori, Souichi, Fujimoto, Katsuya, Nishimura, Machiko, Hatanaka, Kanako C., Kosugi-Kanaya, Mizuha, Okada, Kohei, Sugita, Junichi, Shigematsu, Akio, Hashimoto, Daigo, Endo, Tomoyuki, Kondo, Takeshi, Abe, Riichiro, Hashino, Satoshi, Matsuno, Yoshihiro, Shimizu, Hiroshi, and Teshima, Takanori

Abstract

Advanced-stage mycosis fungoides and Sezary syndrome (MF/SS) have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (HSCT), particularly using a reduced-intensity conditioning (RIC) regimen, is a promising treatment for advanced-stage MF/SS. We performed RIC-HSCT in nine patients with advanced MF/SS. With a median follow-up period of 954days after HSCT, the estimated 3-year overall survival was 85.7% (95% confidence interval, 33.4-97.9%) with no non-relapse mortality. Five patients relapsed after RIC-HSCT; however, in four patients whose relapse was detected only from the skin, persistent complete response was achieved in one patient, and the disease was manageable in other three patients by the tapering of immunosuppressants and donor lymphocyte infusion, suggesting that graft-versus-lymphoma effect and "down-staging" effect from advanced stage to early stage by HSCT improve the prognosis of advanced-stage MF/SS. These results suggest that RIC-HSCT is an effective treatment for advanced MF/SS.

Published
2016

13. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome

Author

1000000645905, Shiratori, Souichi, Fujimoto, Katsuya, Nishimura, Machiko, Hatanaka, Kanako C., Kosugi-Kanaya, Mizuha, Okada, Kohei, Sugita, Junichi, Shigematsu, Akio, Hashimoto, Daigo, Endo, Tomoyuki, 1000070333606, Kondo, Takeshi, 1000060344511, Abe, Riichiro, 1000060271665, Hashino, Satoshi, 1000000199829, Matsuno, Yoshihiro, 1000000146672, Shimizu, Hiroshi, 1000040284096, Teshima, Takanori, 1000000645905, Shiratori, Souichi, Fujimoto, Katsuya, Nishimura, Machiko, Hatanaka, Kanako C., Kosugi-Kanaya, Mizuha, Okada, Kohei, Sugita, Junichi, Shigematsu, Akio, Hashimoto, Daigo, Endo, Tomoyuki, 1000070333606, Kondo, Takeshi, 1000060344511, Abe, Riichiro, 1000060271665, Hashino, Satoshi, 1000000199829, Matsuno, Yoshihiro, 1000000146672, Shimizu, Hiroshi, 1000040284096, and Teshima, Takanori

Abstract

Advanced-stage mycosis fungoides and Sezary syndrome (MF/SS) have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (HSCT), particularly using a reduced-intensity conditioning (RIC) regimen, is a promising treatment for advanced-stage MF/SS. We performed RIC-HSCT in nine patients with advanced MF/SS. With a median follow-up period of 954days after HSCT, the estimated 3-year overall survival was 85.7% (95% confidence interval, 33.4-97.9%) with no non-relapse mortality. Five patients relapsed after RIC-HSCT; however, in four patients whose relapse was detected only from the skin, persistent complete response was achieved in one patient, and the disease was manageable in other three patients by the tapering of immunosuppressants and donor lymphocyte infusion, suggesting that graft-versus-lymphoma effect and "down-staging" effect from advanced stage to early stage by HSCT improve the prognosis of advanced-stage MF/SS. These results suggest that RIC-HSCT is an effective treatment for advanced MF/SS.

Published
2016

15. Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation

Author

Nishida, Mutsumi, primary, Shigematsu, Akio, additional, Sato, Megumi, additional, Kudo, Yusuke, additional, Omotehara, Satomi, additional, Horie, Tatsunori, additional, Iwai, Takahito, additional, Endo, Tomoyuki, additional, Iguchi, Akihiro, additional, Shibuya, Hitoshi, additional, Hatanaka, Kanako, additional, Shimizu, Chikara, additional, and Teshima, Takanori, additional

Published
2015
Full Text
View/download PDF

17. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome

Author

Shiratori, Souichi, primary, Fujimoto, Katsuya, additional, Nishimura, Machiko, additional, Hatanaka, Kanako C., additional, Kosugi-Kanaya, Mizuha, additional, Okada, Kohei, additional, Sugita, Junichi, additional, Shigematsu, Akio, additional, Hashimoto, Daigo, additional, Endo, Tomoyuki, additional, Kondo, Takeshi, additional, Abe, Riichiro, additional, Hashino, Satoshi, additional, Matsuno, Yoshihiro, additional, Shimizu, Hiroshi, additional, and Teshima, Takanori, additional

Published
2014
Full Text
View/download PDF

18. Stenotrophomonas maltophiliainfection during allogeneic hematopoietic stem cell transplantation: a single-center experience

Author

Shiratori, Souichi, primary, Wakasa, Kentaro, additional, Okada, Kohei, additional, Sugita, Junichi, additional, Akizawa, Koji, additional, Shigematsu, Akio, additional, Hashimoto, Daigo, additional, Fujimoto, Katsuya, additional, Endo, Tomoyuki, additional, Kondo, Takeshi, additional, Shimizu, Chikara, additional, Hashino, Satoshi, additional, and Teshima, Takanori, additional

Published
2014
Full Text
View/download PDF

19. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion

Author

Onozawa, Masahiro, primary, Ohmura, Kazumasa, additional, Ibata, Makoto, additional, Iwasaki, Junko, additional, Okada, Kohei, additional, Kasahara, Ikumi, additional, Yamaguchi, Keisuke, additional, Kubota, Kanako, additional, Fujisawa, Shinichi, additional, Shigematsu, Akio, additional, Endo, Tomoyuki, additional, Kondo, Takeshi, additional, Hashino, Satoshi, additional, Tanaka, Junji, additional, Matsuno, Yoshihiro, additional, Asaka, Masahiro, additional, and Imamura, Masahiro, additional

Published
2011
Full Text
View/download PDF

20. Reduced intensity conditioning regimen with fludarabine, busulfan, and low‐dose TBI (Flu‐BU2‐TBI): Clinical efficacy in high‐risk patients

Author

Takahata, Mutsumi, primary, Hashino, Satoshi, additional, Okada, Kohei, additional, Onozawa, Masahiro, additional, Kahata, Kaoru, additional, Sugita, Junichi, additional, Shigematsu, Akio, additional, Kondo, Takeshi, additional, Yamamoto, Satoshi, additional, Endo, Tomoyuki, additional, Nishio, Mitsufumi, additional, Ito, Yoichi M., additional, Tanaka, Junji, additional, Koike, Takao, additional, Asaka, Masahiro, additional, and Imamura, Masahiro, additional

Published
2010
Full Text
View/download PDF

23. FCGR3A‐158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non‐Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation

Author

Nishio, Mitsufumi, primary, Endo, Tomoyuki, additional, Fujimoto, Katsuya, additional, Yamamoto, Satoshi, additional, Obara, Masato, additional, Yamaguchi, Keisuke, additional, Takeda, Yukari, additional, Goto, Hideki, additional, Kasahara, Ikumi, additional, Sato, Norihiro, additional, and Koike, Takao, additional

Published
2009
Full Text
View/download PDF

25. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation

Author

Nishio, Mitsufumi, primary, Fujimoto, Katsuya, additional, Yamamoto, Satoshi, additional, Endo, Tomoyuki, additional, Sakai, Toshiya, additional, Obara, Masato, additional, Kumano, Kohki, additional, Yamaguchi, Keisuke, additional, Takeda, Yukari, additional, Goto, Hideki, additional, Sato, Norihiro, additional, Koizumi, Kazuki, additional, Mukai, Masaya, additional, and Koike, Takao, additional

Published
2007
Full Text
View/download PDF

26. Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma

Author

Nishio, Mitsufumi, primary, Fujimoto, Katsuya, additional, Yamamoto, Satoshi, additional, Endo, Tomoyuki, additional, Sakai, Toshiya, additional, Obara, Masato, additional, Kumano, Kohki, additional, Minauchi, Koichiro, additional, Yamaguchi, Keisuke, additional, Takeda, Yukari, additional, Sato, Norihiro, additional, Koizumi, Kazuki, additional, Mukai, Masaya, additional, and Koike, Takao, additional

Published
2006
Full Text
View/download PDF

27. Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia

Author

Nishio, Mitsufumi, primary, Endo, Tomoyuki, additional, Fujimoto, Katusya, additional, Sato, Norihiro, additional, Sakai, Toshiya, additional, Obara, Masato, additional, Kumano, Koti, additional, Minauchi, Koichiro, additional, and Koike, Takao, additional

Published
2005
Full Text
View/download PDF

28. Incidence and Characteristics of Ventricular Fibrillation in Bystander‐witnessed Out‐of‐hospital Cardiac Arrest with Cardiac Etiology in the City of Sendai, Japan

Author

Watanabe, Jun, primary, Kanazawa, Masaharu, additional, Yagi, Tetsuo, additional, Odakura, Hironori, additional, Kameyama, Motonobu, additional, Sakurai, Katsuhiko, additional, Hiramoto, Tetsuya, additional, Uenohara, Hiroshi, additional, Endo, Tomoyuki, additional, Koseki, Yoshito, additional, Shinozaki, Tsuyoshi, additional, Shiba, Nobuyuki, additional, Karibe, Akihiko, additional, Sakuma, Masahito, additional, Fukuda, Koji, additional, Kagaya, Yutaka, additional, Numakura, Katsunori, additional, Yamaki, Masayuki, additional, Shinozawa, Yotaro, additional, and Shirato, Kunio, additional

Published
2005
Full Text
View/download PDF

30. Balloon pulmonary angioplasty under awake veno-arterial extracorporeal membrane oxygenation in a patient with class III obesity with chronic thromboembolic pulmonary hypertension complicated with multiple serious comorbidities.

Author

Sato T, Fukui S, Nakano T, Hasegawa K, Kikuta H, Kameyama T, Shirota Y, Endo T, Kawamoto S, Kumagai K, Izawa H, and Komaru T

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic disease that can rapidly deteriorate into circulatory collapse when complicated by comorbidities. We herein describe a case involving a 43-year-old woman with class III obesity (body mass index of 63 kg/m 2 ) and severe CTEPH associated with total occlusion of the left main pulmonary artery who subsequently developed circulatory collapse along with multiple comorbidities, including acute kidney injury, pulmonary tuberculosis, and catastrophic antiphospholipid syndrome. The patient was successfully treated with two sessions of rescue balloon pulmonary angioplasty with veno-arterial extracorporeal membrane oxygenation (V-A ECMO) support under local anesthesia without sedation, at cannulation and during the V-A ECMO run, to avoid invasive mechanical ventilation. This case suggests the potential usefulness of rescue balloon pulmonary angioplasty under awake V-A ECMO support for rapidly deteriorating, inoperable CTEPH in a patient with class III obesity complicated with multiple comorbidities., Competing Interests: The authors declare no conflict of interest., (© 2024 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results